Applicability of EU(7)-PIM criteria in cross-national studies in European countries-Reference-Cited by-同舟云学术

Applicability of EU(7)-PIM criteria in cross-national studies in European countries

Published:2019-01 Issue: Volume:10 Page:204209861985401
ISSN:2042-0986
Container-title:Therapeutic Advances in Drug Safety
language:en
Short-container-title:Therapeutic Advances in Drug Safety

Author:

Fialová Daniela¹²^ORCID,Brkić Jovana³,Laffon Blanca⁴,Reissigová Jindra⁵,Grešáková Silvia³,Dogan Soner⁶,Doro Peter⁷,Tasić Ljiljana⁸,Marinković Valentina⁸,Valdiglesias Vanessa⁴,Costa Solange⁹¹⁰,Kostřiba Jan³

Affiliation:

1. Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, Hradec Králové 500 05, Czech Republic

2. Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Prague, Czech Republic

3. Department of Social and Clinical Pharmacy, Charles University, Czech Republic

4. DICOMOSA Group, Department of Psychology, Universidade da Coruña, A Coruña, Spain

5. Department of Statistical Modeling, The Czech Academy of Sciences, Prague, Czech Republic

6. Department of Medical Biology, Yeditepe University, Istanbul, Turkey

7. Department of Clinical Pharmacy, University of Szeged, Szeged, Hungary

8. Department of Social Pharmacy and Pharmaceutical Legislation, University of Belgrade, Belgrade, Serbia

9. Department of Environmental Health, Portuguese National Institute of Health, Porto, Portugal

10. EPIUnit, University of Porto, Porto, Portugal

Funder

INOMED, co-funded by the European Union

EU COST Action

H2020 Marie Skłodowska-Curie Actions

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Link

http://journals.sagepub.com/doi/pdf/10.1177/2042098619854014

Reference37 articles.

1. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice.

2. Review of structured guides for deprescribing

3. Explicit Criteria for Determining Inappropriate Medication Use in Nursing Home Residents

4. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

5. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper;European Geriatric Medicine;2023-10-09

2. Assessment of potentially inappropriate medication use among geriatric outpatients in the Slovak Republic;BMC Geriatrics;2023-09-15

3. Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes;Frontiers in Pharmacology;2023-08-02

4. Evaluating Potentially Inappropriate Medications in the Elderly with Seven Different Screening Tools;Turkish journal of Geriatrics;2023

5. Evaluation of potentially inappropriate medication in older patients with cardiovascular diseases—STOPP/START-based study;Frontiers in Public Health;2022-12-22